CritPath AI brings AI-driven schedule math to R&D project management

R&D programs live or die by their schedules. Yet most teams still manage timelines with spreadsheets, gut instinct, and frantic rescheduling sessions when vendors slip or experiments fail. CritPath AI is changing that by combining Critical Chain Project Management (CCPM), Monte Carlo simulations, and a schedule-aware AI copilot into a single platform designed specifically for R&D’s unique challenges.

CritPath AI isn’t just another project management tool—it’s a schedule-risk management engine that runs real math over your dependency network to show how solid each date actually is. When risks materialize, it reschedules automatically and surfaces what’s driving the risk. The result? Teams can focus on decisions, not spreadsheets, while giving boards and regulators dates they can actually defend.

Why R&D needs more than just a Gantt chart

Traditional project management tools like Asana, Monday, or even Linear excel at task tracking and collaboration. But R&D programs operate in a world of high uncertainty, external dependencies, and regulatory scrutiny—where a single vendor delay can cascade into weeks of lost runway. Generic PM tools lack the mathematical rigor needed to model that uncertainty accurately.

CritPath AI fills this gap by integrating three critical methodologies:

• Critical Path Method (CPM): Identifies the longest sequence of dependent tasks that determines your project’s duration.
• Critical Chain Project Management (CCPM): Adds buffer management and bottleneck identification to account for human behavior and resource contention.
• Monte Carlo simulation: Runs 10,000 iterations over your dependency network to generate defensible date ranges and P90 finish dates—critical for regulatory submissions and investor reporting.

The platform’s decision gates act as first-class schedule objects, ensuring every Go/No-Go or pivot decision triggers fresh schedule math. This level of rigor is rare outside legacy enterprise tools like Primavera or Deltek, which come with steep learning curves, Windows-only desktop clients, and price tags north of $10,000 per seat.

The AI copilot that actually understands your schedule

CritPath AI’s most innovative feature is its schedule-aware AI copilot, powered by Claude and Gemini. Unlike generic AI assistants that treat your project plan as just another document, CritPath’s AI agents reason over your live schedule to propose updates for human approval.

Here’s how it works in practice:

1. A vendor slip or experiment failure triggers a risk event.
2. The AI copilot analyzes the impact on your dependency network, resource constraints, and buffer consumption.
3. It proposes a rescheduled plan with updated dates, new critical paths, and risk drivers highlighted.
4. A named human reviewer approves or modifies the changes, with every action logged in a tamper-evident audit trail.

This human-in-the-loop approach ensures accountability while automating the tedious math. CritPath also offers configurable AI employees (Estimator, Risk Analyst, sub-PM) that can be deployed for specific tasks, billed per completed job at an estimated token cost plus margin. No credits, no hourly minimums, and failed runs don’t incur charges.

Regulatory-grade rigor for high-stakes R&D

For biotech startups racing toward IND filings or federally funded researchers managing grant milestones, auditability and compliance aren’t optional. CritPath positions itself as meeting AACE RP 132R-23 Level 4 standards for risk-driven scheduling, with features like:

• Tamper-evident hash chains for every change
• Human approval + audit trail on AI-generated updates
• 21 CFR Part 11 compliance on the Enterprise roadmap

While legacy tools like Pertmaster offer similar rigor, they lack the modern, self-serve UX that CritPath provides. The platform’s transparent pricing—$10/user/month for all features—also stands in stark contrast to enterprise risk tools that require custom quotes and long sales cycles.

Transparent AI billing: No black-box surprises

AI project management tools often hide costs behind opaque credit systems or minimum usage fees. CritPath takes a different approach:

• AI usage is billed per completed job, with costs based on estimated token usage plus a stated platform margin.
• Failed runs don’t incur charges—you only pay when the AI delivers a usable result.
• No credits, no hourly minimums, and no surprise burn during peak usage.

This model aligns incentives: CritPath profits when the AI helps you, not when it spins in circles. It’s a refreshing contrast to competitors like Viktor or Lindy, which charge $50–$894 per month plus credits, often with little visibility into how those credits are consumed.

Who should (and shouldn’t) use CritPath AI

CritPath AI is built for teams where schedule uncertainty is the norm, not the exception. Ideal users include:

• Biotech program leaders managing IND-enabling studies
• Deep-tech founders with complex dependency chains
• Federally funded principal investigators (PIs) reporting to grant agencies
• Grant program managers tracking milestone compliance

The platform is not designed for teams expecting simple task management or those without complex dependency networks. If your project resembles a straightforward to-do list, tools like Linear or Asana will likely suffice.

CritPath operates on a waitlist-only Pro plan ($10/user/month) and a sales-led Enterprise tier with features like dedicated CSM, custom integrations, on-prem deployment, SOC 2, SAML, and HIPAA BAA support.

Real-world impact: Speed and accuracy that matter

CritPath claims its engine delivers measurable benefits:

• 65 seconds to reschedule a tox-study slip, compared to a day of manual work
• 10,000-run Monte Carlo simulations in seconds, validated against academic scheduling benchmarks
• Cost-of-delay calculations baked into prioritization and staffing decisions (e.g., $800K/day late-stage pharma costs)

While these claims are company statements rather than independently verified benchmarks, they align with the experiences of teams managing high-stakes R&D programs. The key differentiator isn’t just the speed—it’s the defensibility of the dates produced. For teams answering to investors, regulators, or grant agencies, that’s a game-changer.

Integrations and roadmap: Where CritPath is headed

CritPath’s integration strategy focuses on developer and collaboration tools that R&D teams already use:

• GitHub (currently in active use)
• Slack, Notion, and Discord (near-term roadmap)

The platform’s API is available for custom integrations, and future updates include on-prem deployment options and expanded compliance features like 21 CFR Part 11 for Enterprise customers.

How CritPath AI compares to alternatives

CritPath’s unique value lies in its combination of mathematical rigor, AI automation, and regulatory readiness—areas where both legacy enterprise tools and generic PM platforms fall short.

Getting started with CritPath AI

CritPath AI is currently waitlist-only for Pro and sales-led for Enterprise. If you’re managing an R&D program with complex dependencies, external risks, or regulatory requirements, it’s worth evaluating how much time your team spends on manual rescheduling versus actual decision-making.

The $10/user/month pricing makes it accessible for small teams, while the Enterprise tier offers the compliance and customization needed for larger organizations. Whether you’re a biotech startup racing toward an IND filing or a federally funded researcher tracking grant milestones, CritPath AI provides the schedule math and AI copilot to keep your program on track.

Find More on LiftOff

LiftOff is a product launch platform built for makers and indie developers. If you are building something and want it in front of an audience that cares, submit your product and join the community.